Quantification of placental extracellular vesicles in different pregnancy status via single particle analysis method

Clin Chim Acta. 2023 Jan 15:539:266-273. doi: 10.1016/j.cca.2022.12.021. Epub 2022 Dec 30.

Abstract

Background: The nano-sized, lipid bilayer-delimited placental extracellular vesicles (PEVs) released by the placenta are now regarded as important mediators involved in various physiological and pathological processes of pregnant women. The number and contents of PEVs are significantly altered in preeclampsia and are considered as potential biomarkers. However, the distribution pattern of PEVs in the maternal circulation in different pregnancy status is still unclear for the limitation of the traditional method with low sensitivity.

Methods: In this work, we recruited 561 pregnant women with different pregnancy status and investigated the distribution pattern of PEVs in the maternal circulation based on a single extracellular vesicle analysis method and placental alkaline phosphatase (PLAP), a placenta-specific marker.

Results: The concentration of PEVs in pregnant women increased with the progression of gestational age, while the ratio of PEVs decreased to about 10% in the third trimester. Surprisingly, the PLAP+ EVs also presented in the plasma of non-pregnant women and normal male about 5%. The change in the ratio of PEVs can reflect the pregnancy status and also had a better diagnostic value in severe preeclampsia (AUC = 0.7811).

Conclusions: Our study not only reveals the distribution pattern of PEVs, but also identifies the diagnostic potential of PEVs as biomarkers.

Keywords: Extracellular vesicles; Placenta; Pregnancy status; Single particle analysis.

MeSH terms

  • Biomarkers
  • Extracellular Vesicles*
  • Female
  • Humans
  • Male
  • Placenta
  • Pre-Eclampsia* / diagnosis
  • Pregnancy
  • Single Molecule Imaging

Substances

  • Biomarkers